170 related articles for article (PubMed ID: 38279513)
1. Role of catecholamine synthases in the maintenance of cancer stem-like cells in malignant peripheral nerve sheath tumors.
Katayama H; Fujimura A; Huang R; Otani Y; Itano T; Fujiwara T; Kunisada T; Nakata E; Ozaki T
Cancer Sci; 2024 Mar; 115(3):871-882. PubMed ID: 38279513
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic signaling promotes the expansion of cancer stem-like cells of malignant peripheral nerve sheath tumors.
Huang R; Fujimura A; Nakata E; Takihira S; Inoue H; Yoshikawa S; Hiyama T; Ozaki T; Kamiya A
Biochem Biophys Res Commun; 2021 Jun; 557():199-205. PubMed ID: 33872989
[TBL] [Abstract][Full Text] [Related]
3. Decorin suppresses stemness and migration potential of malignant peripheral nerve sheath tumor through inhibiting epidermal growth factor receptor signaling.
Jia X; Chen L; Yu C
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167181. PubMed ID: 38653361
[TBL] [Abstract][Full Text] [Related]
4. Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.
Wu LMN; Deng Y; Wang J; Zhao C; Wang J; Rao R; Xu L; Zhou W; Choi K; Rizvi TA; Remke M; Rubin JB; Johnson RL; Carroll TJ; Stemmer-Rachamimov AO; Wu J; Zheng Y; Xin M; Ratner N; Lu QR
Cancer Cell; 2018 Feb; 33(2):292-308.e7. PubMed ID: 29438698
[TBL] [Abstract][Full Text] [Related]
5. LPAR1 and aberrantly expressed LPAR3 differentially promote the migration and proliferation of malignant peripheral nerve sheath tumor cells.
Doutt SW; Longo JF; Carroll SL
Glia; 2023 Mar; 71(3):742-757. PubMed ID: 36416236
[TBL] [Abstract][Full Text] [Related]
6. Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.
Wu LMN; Zhang F; Rao R; Adam M; Pollard K; Szabo S; Liu X; Belcher KA; Luo Z; Ogurek S; Reilly C; Zhou X; Zhang L; Rubin J; Chang LS; Xin M; Yu J; Suva M; Pratilas CA; Potter S; Lu QR
Sci Adv; 2022 Nov; 8(44):eabo5442. PubMed ID: 36322658
[TBL] [Abstract][Full Text] [Related]
7. Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.
Suppiah S; Mansouri S; Mamatjan Y; Liu JC; Bhunia MM; Patil V; Rath P; Mehani B; Heir P; Bunda S; Velez-Reyes GL; Singh O; Ijad N; Pirouzmand N; Dalcourt T; Meng Y; Karimi S; Wei Q; Nassiri F; Pugh TJ; Bader GD; Aldape KD; Largaespada DA; Zadeh G
Nat Commun; 2023 May; 14(1):2696. PubMed ID: 37164978
[TBL] [Abstract][Full Text] [Related]
8. Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.
Miller SJ; Rangwala F; Williams J; Ackerman P; Kong S; Jegga AG; Kaiser S; Aronow BJ; Frahm S; Kluwe L; Mautner V; Upadhyaya M; Muir D; Wallace M; Hagen J; Quelle DE; Watson MA; Perry A; Gutmann DH; Ratner N
Cancer Res; 2006 Mar; 66(5):2584-91. PubMed ID: 16510576
[TBL] [Abstract][Full Text] [Related]
9. Malignant peripheral nerve sheath tumors.
Gupta G; Maniker A
Neurosurg Focus; 2007 Jun; 22(6):E12. PubMed ID: 17613203
[TBL] [Abstract][Full Text] [Related]
10. VEGF and VEGFR family members are expressed by neoplastic cells of NF1-associated tumors and may play an oncogenic role in malignant peripheral nerve sheath tumor growth through an autocrine loop.
Bonsang B; Maksimovic L; Maille P; Martin N; Laurendeau I; Pasmant E; Bièche I; Deschamps J; Wolkenstein P; Ortonne N
Ann Diagn Pathol; 2022 Oct; 60():151997. PubMed ID: 35777330
[TBL] [Abstract][Full Text] [Related]
11. HIPPO Stampede in Nerve Sheath Tumors.
Feltri ML; Poitelon Y
Cancer Cell; 2018 Feb; 33(2):160-161. PubMed ID: 29438691
[TBL] [Abstract][Full Text] [Related]
12. Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis.
González-Muñoz T; Di Giannatale A; García-Silva S; Santos V; Sánchez-Redondo S; Savini C; Graña-Castro O; Blanco-Aparicio C; Fischer S; De Wever O; Creus-Bachiller E; Ortega-Bertran S; Pisapia DJ; Rodríguez-Peralto JL; Fernández-Rodríguez J; Pérez-Portabella CR; Alaggio R; Benassi MS; Pazzaglia L; Scotlandi K; Ratner N; Yohay K; Theuer CP; Peinado H
Clin Cancer Res; 2023 Sep; 29(18):3744-3758. PubMed ID: 37432984
[TBL] [Abstract][Full Text] [Related]
13. Malignant Peripheral Nerve Sheath Tumors of the Brachial Plexus: A Single-Center Experience on Diagnosis, Management, and Outcomes.
Donaldson EK; Winter JM; Chandler RM; Clark TA; Giuffre JL
Ann Plast Surg; 2023 Apr; 90(4):339-342. PubMed ID: 36752552
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Erb-B2 Receptor Tyrosine Kinase 3 and Associated Regulatory Pathways Potently Impairs Malignant Peripheral Nerve Sheath Tumor Proliferation and Survival.
Black LE; Longo JF; Anderson JC; Carroll SL
Am J Pathol; 2023 Sep; 193(9):1298-1318. PubMed ID: 37328102
[TBL] [Abstract][Full Text] [Related]
15. Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.
Sun D; Xie XP; Zhang X; Wang Z; Sait SF; Iyer SV; Chen YJ; Brown R; Laks DR; Chipman ME; Shern JF; Parada LF
Cell Stem Cell; 2021 Aug; 28(8):1397-1410.e4. PubMed ID: 34010628
[TBL] [Abstract][Full Text] [Related]
16. HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis.
Palomo-Irigoyen M; Pérez-Andrés E; Iruarrizaga-Lejarreta M; Barreira-Manrique A; Tamayo-Caro M; Vila-Vecilla L; Moreno-Cugnon L; Beitia N; Medrano D; Fernández-Ramos D; Lozano JJ; Okawa S; Lavín JL; Martín-Martín N; Sutherland JD; de Juan VG; Gonzalez-Lopez M; Macías-Cámara N; Mosén-Ansorena D; Laraba L; Hanemann CO; Ercolano E; Parkinson DB; Schultz CW; Araúzo-Bravo MJ; Ascensión AM; Gerovska D; Iribar H; Izeta A; Pytel P; Krastel P; Provenzani A; Seneci P; Carrasco RD; Del Sol A; Martinez-Chantar ML; Barrio R; Serra E; Lazaro C; Flanagan AM; Gorospe M; Ratner N; Aransay AM; Carracedo A; Varela-Rey M; Woodhoo A
J Clin Invest; 2020 Jul; 130(7):3848-3864. PubMed ID: 32315290
[TBL] [Abstract][Full Text] [Related]
17. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Ristow I; Madesta F; Well L; Shenas F; Wright F; Molwitz I; Farschtschi S; Bannas P; Adam G; Mautner VF; Werner R; Salamon J
Neuro Oncol; 2022 Oct; 24(10):1790-1798. PubMed ID: 35426432
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.
Yang K; Guo W; Ren T; Huang Y; Han Y; Zhang H; Zhang J
J Exp Clin Cancer Res; 2019 May; 38(1):185. PubMed ID: 31053152
[TBL] [Abstract][Full Text] [Related]
20. Secretome analysis of human schwann cells derived from malignant peripheral nerve sheath tumor.
Ferdoushi A; Jamaluddin MFB; Li X; Pundavela J; Faulkner S; Hondermarck H
Proteomics; 2022 Jan; 22(1-2):e2100063. PubMed ID: 34648240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
